Akademisyen
ERDEM ÇUBUKÇU
PROFESÖR
BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 74
- Proje 0
- Kitap 0
- Bildiri 69
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
7
Q2
15
Q3
17
Q4
4
WoS (JCR)
Q1
3
Q2
5
Q3
9
Q4
25
TR Index
18
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
76.6%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2022 Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma YÖKSİS SJR Q2 JCR Q2
- 2022 Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors YÖKSİS SJR Q3 JCR Q4
- 2022 Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2 YÖKSİS SJR Q1 JCR Q3
- 2022 Trastuzumab\u2009±\u2009Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group YÖKSİS SJR Q3 JCR Q4
- 2021 Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy YÖKSİS SJR Q1 JCR Q2
- 2021 Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer YÖKSİS SJR Q1 JCR Q1
- 2021 Efficacy of chemotherapeutics on classic and non-classic Kaposi sarcoma: A single-center retrospective real-world study YÖKSİS SJR Q2 JCR Q3
- 2021 Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer YÖKSİS SJR Q3 JCR Q4
- 2021 The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer YÖKSİS SJR Q4 JCR Q4
- 2021 DPYD c.1905+1G>A Promotes Fluoropyrimidine-Driven Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer YÖKSİS SJR Q3 JCR Q4
- 2021 The impact of Ki-67 index, squamous differentiation and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer YÖKSİS SJR Q2 JCR Q3
- 2021 Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer: real world experience YÖKSİS SJR Q2 JCR Q4 OpenAlex 76.6%
- 2021 The Importance of Platinum Sensitivity in Metastatic Malignant Pleural Mesothelioma Patients YÖKSİS TR Index
- 2021 Prognostic Significance of Microsatellite Instability in Turkish Patients with Stage II and III Colorectal Cancer YÖKSİS TR Index
- 2020 Chemo-Immunotherapy with Atezolizumab in Extensive-Stage Small-Cell Lung Cancer; Single-Center Experience YÖKSİS TR Index SJR Q4 JCR Q4
- 2020 Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients YÖKSİS SJR Q2 JCR Q3
- 2020 The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans YÖKSİS SJR Q2 JCR Q3
- 2020 Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study YÖKSİS TR Index SJR Q4
- 2020 Tolvaptan in the Treatment of Syndrome of Inappropriate Anti-Diuretic Hormone in Cancer Patients YÖKSİS TR Index
- 2020 Osimertinib in Resected EGFR-Mutated Non\u2013Small-Cell Lung Cancer YÖKSİS SJR Q1 JCR Q1